Term
1. What are some characteristics of the ideal antimicrobial drug? |
|
Definition
Selectively toxic to microbe but nontoxic to host cells Microbicidal Relatively soluble; functions even when highly diluted in body fluids Remains potent long enough to act and is not broken down or excreted prematurely Doesn’t lead to the development of antimicrobial resistance Complements or assists the activities of the host’s defenses Remains active in tissues and body fluids Readily delivered to site of infection Reasonably priced Does not disrupt the host’s health by causing allergies or predisposing the host to other infections |
|
|
Term
2. Any chemical used in treatment, relief, or prophylaxis of a disease is called |
|
Definition
Chemotherapeutic drug prophylaxis |
|
|
Term
3. Use of a drug to prevent potential for infection of a person at risk is called |
|
Definition
|
|
Term
4. The use of chemotherapeutic drugs to control infection is called |
|
Definition
Antimicrobial chemotherapy |
|
|
Term
5. “antimicrobial drug” is commonly known as |
|
Definition
|
|
Term
6. Substances produced by the natural metabolic processes of some microorganisms that can inhibit or destroy other microorganisms are called |
|
Definition
|
|
Term
7. Drugs that are chemically modified in the laboratory after being isolated from natural sources |
|
Definition
|
|
Term
8. The use of chemical reactions to synthesize antimicrobial compounds in the lab |
|
Definition
|
|
Term
9. Antimicrobials effective against a limited array of microbial types are |
|
Definition
9. Narrow spectrum (limited spectrum) |
|
|
Term
10. Antimicrobials effective against a wide variety of microbial types are |
|
Definition
10. Broad spectrum (extended spectrum) |
|
|
Term
are common metabolic products of aerobic spore-forming bacterial and fungi |
|
Definition
|
|
Term
12. Describe the different targets of antimicrobial drugs |
|
Definition
12. Inhibition of cell wall synthesis Breakdown of the cell membrane structure or function Inhibition of nubleic acid synthesis, structure or function Inhibition of protein synthesis Blocking of key metabolic pathways |
|
|
Term
13. These drugs are cell wall inhibitors |
|
Definition
13. Penicillins, cephalosporins, vancomycin |
|
|
Term
14. These drugs are protein synthesis inhibitors acting on ribosomes. |
|
Definition
14. Chloramphenicol, erythromycin, clindamycin, streptogramin (synercid |
|
|
Term
15. ________ and __________ block synthesis of peptidoglycan causing lysis on the cell wall. |
|
Definition
15. Penicillin and cephalosporin |
|
|
Term
16. _______ do not penetrate the outer membrane and are less effective against gram-negative bacteria |
|
Definition
|
|
Term
17. Can broad spectrum penicillins and cephalosporings cross the cell walls of gram-negaritive bacteria? |
|
Definition
|
|
Term
18. What do polymyxins do? |
|
Definition
18. They interact with phospholipids and cause leakage, particulary in gram-negative bacteria. |
|
|
Term
19. Which 2 drugs form complexes with sterols on fungal membranes that causes leakage |
|
Definition
19. Amphotericin B and nystatin |
|
|
Term
20. What purpose do aminoglycosides (streptomycin and gentamicin) serve? |
|
Definition
20. They insert on sites on the 30S subunit and cause misreading of the Mrna |
|
|
Term
21. _______block attachment of tRNA on the A acceptor site and stop further synthesis. |
|
Definition
|
|
Term
22. What is it called when a drug competes with normal substrate for enzyme’s active site? |
|
Definition
22. Competitive inhibition |
|
|
Term
23. This is an additive effect, achieved by multiple drugs working together, requiring a lower dose of each |
|
Definition
|
|
Term
24. Name 3 antibiotics that affect the cell wall |
|
Definition
24. Penicillins, cephalosporins, beta-lactam antibiotics |
|
|
Term
25. Antibiotics that damage the cell membrane are called |
|
Definition
|
|
Term
26. Name 2 antibiotics that act on DNA or RNA |
|
Definition
26. Fluoroquinolones and rifampin |
|
|
Term
27. These 4 antibiotics interfere with protein synthesis |
|
Definition
27. Aminoglyosides, tetracycline antibiotics, chloramphenicol, macrolides |
|
|
Term
28. Antibiotics that block metabolic pathways |
|
Definition
|
|
Term
29. What is the drug of choice for gram-positive cocci (streptococci) and some gram-negative bacteria (meningococci and syphilis spirochete) |
|
Definition
|
|
Term
30. What are some examples of semisynthetic penicillins? |
|
Definition
30. Amipcillin, carbenicillin, amoxicillin have broader spectra-gram negative enteric rods |
|
|
Term
31. What are some examples of penicillinase-resistant |
|
Definition
31. Methicillin, nafcillin, cloxacillin |
|
|
Term
32. What are the primary problems with penicillins |
|
Definition
32. Allergies and resistant strains of bacteria |
|
|
Term
33. What is the enzyme called that breaks the beta-lactam ring and is the cause for resistance to the beta-lactam antibiotics |
|
Definition
33. Beta-lactamase (penicillanase) |
|
|
Term
34. This ring is a key structure in certain antibiotics that inhibit the bacterial cell wall synthesis |
|
Definition
|
|
Term
35. This acid is an additive that makes an antibiotic resistant to the beta-lactamase produced by resistant bacteria. It is added to amoxicillin to make augmentin |
|
Definition
|
|
Term
36. Describe cephalosporins |
|
Definition
36. Account for majority of all antibiotics administered Isolated from cephalosporium acremonium mold Beta-lactam ring that can be altered Relatively broad-spectrum, resistant to most penicillinases Cause fewer allergic reactions Some given orally, many given parenterally( IM or IV). |
|
|
Term
37. In the cephalosporins group, this generation is most effective against gram-positive cocci |
|
Definition
37. First generation- cephalothin, cefazolin |
|
|
Term
38. This generation is more effective against gram-negative bacteria |
|
Definition
38. Second generation- cefaclor, cefonacid |
|
|
Term
39. This generation has a broad spectrum activity against enteric bacteria with betalactamases |
|
Definition
39. Third generation- cephalexin, cefotaxime |
|
|
Term
40. This generation is the widest spectrum against both gram positives and gram negatives |
|
Definition
40. Fourth generation- cefepime |
|
|
Term
41. This beta-lactam antibiotic is a broad-spectrum drug for infections with aerobic and anaerobic pathogens |
|
Definition
|
|
Term
42. What drug is a newer narrow-spectrum drug for infections by gram-negative aerobic bacilli. It may be used by people allergic to penicillin. |
|
Definition
42. Chromobacterium violaceum |
|
|
Term
43. This is a narrow-spectrum peptide produced by Bacillus subtilis (major ingredient of Neosporin ointment) |
|
Definition
|
|
Term
44. This is a narrow-spectrum peptide with fatty acid component, detergent activity |
|
Definition
|
|
Term
45. These antibiotics act on DNA or RNA and are broad-spectrum, potent, readily absorbed from the intestines |
|
Definition
|
|
Term
46. This antibiotic blocks RNA polymerase preventing transcription. Used to treat TB and leprosy |
|
Definition
|
|
Term
47. These 4 antibiotics interfere with protein synthesis |
|
Definition
47. Aminoglycosides, tetracyclines, chloramphenicol, macrolides |
|
|
Term
48. Composed of 2 or more amino sugars and an aminocyclitol ring |
|
Definition
|
|
Term
49. This aminoglycoside is used for bubonic plague, tularemia, TB |
|
Definition
|
|
Term
50. This aminoglycoside is less toxic, used against gram-negative rods |
|
Definition
|
|
Term
51. These antibiotics bind to ribosomes and block protein synthesis |
|
Definition
51. tetracycline antibiotics |
|
|
Term
52. What are tetracycline antibiotics indicated for |
|
Definition
52. mycoplasma pneumonia, STDs, Rocky mountain spotted fever, Lyme disease, typhus, acne, and some protozoa |
|
|
Term
53. This drug blocks peptide bond formation and is very toxic and can cause irreversible damage to bone marrow- not often used. |
|
Definition
|
|
Term
54. This macrolide has a large lactone ring with sugars and has fairly low toxicity |
|
Definition
|
|
Term
55. Which macrolide is used most commonly |
|
Definition
|
|
Term
56. These antibiotics block metabolic pathways- synthetic drugs |
|
Definition
56. sulfonamides, sulfisoxazole, silver sulfadiazine, trimethoprim |
|
|
Term
57. What were the first antimicrobial drugs? |
|
Definition
|
|
Term
58. Name 4 antifungal drugs |
|
Definition
58. polyenes, griseofulvin, synthetic azoles, flucytosine |
|
|
Term
59. This polyene mimics lipids, most versatile and effective, topical and systemic treatments but can be toxic |
|
Definition
|
|
Term
60. This topical treatment is good against yeast |
|
Definition
|
|
Term
61. This antifungal drug has a lot of side effects |
|
Definition
|
|
Term
62. What are the most commonly used antifungal meds? |
|
Definition
|
|
Term
63. This antifuntal drug is for cutaneous mycoces, vaginal and oral candidiasis and some systemic mycoces |
|
Definition
|
|
Term
64. This antifungal drug is an oral treatment for vaginal candidiasis and AIDS and mycoces |
|
Definition
64. fluconazole (diflucan |
|
|
Term
65. These two antifungal drugs are topical meds for skin, mouth, and vaginal infections. Used for athletes foot and is OTC |
|
Definition
65. Clotrimazole and miconazole |
|
|
Term
66. Name 3 types of antiparasitic drugs |
|
Definition
66. Antimalarial, antiprotozoan, and antihelminthic drugs |
|
|
Term
67. All the “quines” drugs (quinine, chloroquinine, primaquine, meflogquine) are considered |
|
Definition
|
|
Term
68. Metronidazole, quinicrine, sulfonamides, tetracyclines are all |
|
Definition
|
|
Term
69. This antiparasitic drug group immobilize, disintegrate, or inhibit metabolism of worm |
|
Definition
69. Antihelminthic drugs (mebendazole, pyrantel, piperazine, niclosamide) |
|
|
Term
70. These drugs block penetration into host cell |
|
Definition
|
|
Term
71. These antiviral drugs block transcription or translation |
|
Definition
71. Acyclovir (for herpes virus), ribavirin, AZT (for HIV) |
|
|
Term
72. This antiviral drug prevents maturation of viral particles |
|
Definition
72. Protease inhibitors ( for HIV) |
|
|
Term
73. This antiviral drug is used for HCV (hep C) |
|
Definition
|
|
Term
74. What are some mechanisms of drug resistance? |
|
Definition
74. Drug inactivation, decreased permeability to drug or increased elimination of drug from cell, change in metabolic patterns, change in drug receptors |
|
|
Term
75. What are 3 side effects of drugs |
|
Definition
75. Toxicity to organs- liver, kidneys, GI tract, cardio system, nervous system, resp. tract, blood forming tissue, skin, bones, teeth allergic responses-drug acts as an antigen. PCN allergies most common. suppression and alteration of normal flora-causing a “superinfection” |
|
|
Term
76. What are some considerations in selecting an antimicrobial drug |
|
Definition
76. Nature of microbe causing infection degree of microbe’s sensitivity to various drugs toxicity of the drug overall medical condition of patient |
|
|
Term
77. This technique is an in-vitro process that determines susceptibility and resistance |
|
Definition
77. Kirby-Bauer technique |
|
|
Term
78. When is testing needed for drug sensitivity |
|
Definition
78. For groups of bacteria that commonly become resistant to antibiotics |
|
|
Term
79. The smallest concentration of drug that visibly inhibits growth is called____. This aids in determining the lowest effective dose of a drug and is used for comparison studies between antimicrobials. |
|
Definition
79. Minimum inhibitory concentration (MIC) |
|
|
Term
80. The ratio of the dose of the drug that is toxic to humans as compared to its minimum effective (therapeutic) dose is called______. |
|
Definition
|
|
Term
|
Definition
81. The smaller the ratio of the therapeutic index, the higher/lower risk of toxicity to the pt. |
|
|
Term
81. The smaller the ratio of the therapeutic index, the higher/lower risk of toxicity to the pt. |
|
Definition
|
|
Term
82. A higher/lower TI will have a greater margin of safety. |
|
Definition
|
|